What is Oppenheimer's price target for VTYX?

Oppenheimer's latest stated price target for Ventyx Biosciences Inc. (VTYX) is $12, from its action on Mar 12, 2024.

What is Oppenheimer's rating on VTYX?

Oppenheimer rates VTYX Outperform, a bullish rating, as of Mar 12, 2024.

When did Oppenheimer last change its view on VTYX?

On Mar 12, 2024, Oppenheimer upgrades to Outperform from Perform, price target $12.

Oppenheimer VTYX price target and rating history

Ventyx Biosciences Inc. (VTYX) · Health Care

Oppenheimer rates Ventyx Biosciences Inc. (VTYX) Outperform with a $12 price target, as of its latest action on Mar 12, 2024. It has published 3 rating actions on VTYX since February 2022, including 1 upgrade and 1 downgrade.

Current rating: Outperform
Price target: $12
Median target, all firms: Too few
Actions on VTYX: 3

Oppenheimer price target on VTYX

Oppenheimer price target on VTYX, each point a stated target, February 2022 to March 2024.

Every Oppenheimer rating on VTYX

Mar 12, 2024
UpgradeOppenheimer upgrades to Outperform from Perform, price target $12
Nov 7, 2023
DowngradeOppenheimer downgrades to Perform from Outperform
Feb 1, 2022
InitiateOppenheimer starts coverage at Outperform, price target $30

Questions about Oppenheimer and VTYX

What is Oppenheimer's price target for VTYX?: Oppenheimer's latest stated price target for Ventyx Biosciences Inc. (VTYX) is $12, from its action on Mar 12, 2024.
What is Oppenheimer's rating on VTYX?: Oppenheimer rates VTYX Outperform, a bullish rating, as of Mar 12, 2024.
When did Oppenheimer last change its view on VTYX?: On Mar 12, 2024, Oppenheimer upgrades to Outperform from Perform, price target $12.

More VTYX rating histories

All Oppenheimer ratings VTYX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.